Merck shares drop 10% as pharma giant scraps trial of promising cancer drug
Merck & Co called off a Phase III trial of its promising cancer drug Xevinapant after an independent panel concluded it is unlikely to meet its goals
‘Potentially severe Applebee’s same-store sales underperformance vs. peers (based on Truist Card Data) shakes our confidence that improving same-store sales...
JPMorgan Chase & Co. and Wells Fargo & Co. kick off third-quarter earnings season this coming Friday, as Wall Street...
The end of the three-day U.S. ports strike has implications for a number of transportation and shipping stocks, say analysts.
Analysts predict a reversal of two years of earnings declines for the banking industry.
Coeur Mining announced Friday an agreement in which the gold and silver miner is using its stock, that has more...
Rivian’s stock took a dive Friday, after the electric vehicle maker said it was experiencing a supply shortage, prompting a...